The γ-secretase complex: from discovery to a therapeutic target
Open Access
- 5 June 2026
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in RSC Chemical Biology
- Vol. 7 (8) , 1456-1481
Abstract
γ-Secretase is an intricate intramembrane aspartyl protease that cleaves within the transmembrane domain of ∼150 substrates, plays critical roles in biology and disease, and is considered the ‘proteasome of the membrane’.Keywords
Funding Information
- National Institute on Aging (AG66986)
This publication has 295 references indexed in Scilit:
- Alzheimer's disease drug development pipeline: 2026Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2026
- Anti-Amyloid Immunotherapies for Alzheimer's Disease: A 2023 Clinical UpdateNeurotherapeutics, 2023
- Gamma Secretase Inhibitors in Cancer: A Current Perspective on Clinical PerformanceThe Oncologist, 2020
- Tau in Alzheimer’s Disease: Pathological Alterations and an Attractive Therapeutic TargetCurrent Medical Science, 2020
- The vexing complexity of the amyloidogenic pathwayProtein Science, 2019
- Age and amyloid effects on human central nervous system amyloid‐beta kineticsAnnals of Neurology, 2015
- Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer DiseaseArchives of Neurology, 2012
- Substrate specificity of γ-secretase and other intramembrane proteasesCellular and Molecular Life Sciences, 2008
- Identification of a Novel Aspartic Protease (Asp 2) as β-SecretaseMolecular and Cellular Neuroscience, 1999
- Presenilin Proteins Undergo Heterogeneous Endoproteolysis between Thr291and Ala299and Occur as Stable N- and C-Terminal Fragments in Normal and Alzheimer Brain TissueNeurobiology of Disease, 1997